Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
-
See More$7.5 Million Settlement – Meritage Homes of the Carolinas, Inc. v. Town of Holly Springs
Meritage Homes of the Carolinas, Inc. v. Town of Holly Springs, Wake Co. File No. 20-CVS-14511 (NC)$7.5 million class settlement on behalf of developers for illegal recreation fees in lieu of land dedication. -
See More$330+ Million Settlement – Rite Aid Corp. Securities Litigation
In re Rite Aid Corp. Securities Litigation, No. 99-1349 (E.D. Pa.)Milberg served as Co-Lead Counsel in this case, in which plaintiffs asserted federal securities fraud claims based on Rite Aid’s alleged failure to disclose material problems with its store expansion and modernization program resulting in artificially inflated earnings. The court-approved settlements totaled over $330 million. -
See More$775 Million Settlement – Washington Public Power Supply System Securities Litigation
In re Washington Public Power Supply System Securities Litigation, MDL 551 (D. Ariz.)In this massive securities fraud litigation, Milberg served as Co-Lead Counsel for a class that obtained, after several months of trial, settlements totaling $775 million, the largest securities fraud settlement at that time. -
See More$75 Million Settlement – Irvine v. ImClone Systems, Inc.
Irvine v. ImClone Systems, Inc., No. 02-0109 (S.D.N.Y.)Milberg served as Co-Lead Counsel in this case, in which the plaintiffs alleged that ImClone misrepresented the likelihood that its drug, Erbitux, would be approved, thereby artificially inflating the price of ImClone stock. The court approved a $75 million cash settlement in 2005. -
See More$62 Million Settlement – Comverse Technology, Inc. Derivative Litigation
In re Comverse Technology, Inc. Derivative Litigation, No. 601272/2006 (N.Y. Sup. Ct. N.Y. Cnty.)As Co-Lead Counsel, Milberg negotiated a $62 settlement which was approved by the court in 2010. The settlement also resulted in significant corporate governance reforms, including the replacement of various directors and officers; the amendment of the company’s bylaws to permit certain shareholders to propose in the company’s proxy materials nominees for election as directors; and the requirement that all equity grants be approved by both the compensation committee and a majority of the non-employee directors.